Visara appoints ophthalmology leaders to advance VIS-101 drug program
Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program| (NASDAQ: AURA) | Delayed: 7.01 -0.04 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.05 | 52 Week High | $ | |||
| Open | $7.03 | 52 Week Low | $ | |||
| Day High | $7.14 | P/E | N/A | |||
| Day Low | $6.82 | EPS | $ | |||
| Volume | 481,235 | |||||
| (NASDAQ: FDMT) | Delayed: 9.61 -0.24 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.85 | 52 Week High | $ | |||
| Open | $9.82 | 52 Week Low | $ | |||
| Day High | $9.98 | P/E | N/A | |||
| Day Low | $9.39 | EPS | $ | |||
| Volume | 529,754 | |||||
| (NASDAQ: NBP) | Delayed: 1.61 -0.14 (8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.75 | 52 Week High | $6.95 | |||
| Open | $1.75 | 52 Week Low | $6.95 | |||
| Day High | $1.77 | P/E | 0.75 | |||
| Day Low | $1.61 | EPS | $2.14 | |||
| Volume | 296,600 | |||||

